Your browser doesn't support javascript.
Letter to the Editor: Perspectives on mRNA Vaccine Development for Cancer.
Ke, Youqiang.
  • Ke Y; Department of Molecular & Clinical Cancer Medicine, Liverpool University, Liverpool, United Kingdom.
J Interferon Cytokine Res ; 42(11): 592-593, 2022 11.
Article in English | MEDLINE | ID: covidwho-2231738
ABSTRACT
Recently, messenger ribonucleic acid (mRNA) vaccine research and development became a hotspot in the field of prevention and treatment of Corona Virus Disease 2019 (COVID-19) and some other disorders. mRNA vaccine shows many advantages over other vaccines, including cost-effectiveness, safety, and rapid optimization of antigen-specific sequences and shorter development cycle. Cancer progression is significantly associated with immune response, and mRNA vaccine also shows obvious advantages for cancer immunotherapy. In this study, we briefly summarize the recent advances and discuss the perspectives on tumor mRNA vaccine development; particularly, these findings pave an avenue for effective cancer prevention and treatment.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Cancer Vaccines / COVID-19 / Neoplasms Topics: Vaccines Limits: Humans Language: English Journal: J Interferon Cytokine Res Journal subject: Allergy and Immunology Year: 2022 Document Type: Article Affiliation country: Jir.2022.0145

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Cancer Vaccines / COVID-19 / Neoplasms Topics: Vaccines Limits: Humans Language: English Journal: J Interferon Cytokine Res Journal subject: Allergy and Immunology Year: 2022 Document Type: Article Affiliation country: Jir.2022.0145